EUVIMEDEUVIMED entdecken
Crossref

Patient empowerment and access to medicines: Insights from a scientist-patient suffering from erythropoietic protoporphyria

Jasmin Barman-Aksözen

Medicine Access @ Point of Care · 2019

DOI: 10.1177/2399202619865167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicine Access @ Point of Care, 2019. Verfasst von Jasmin Barman-Aksözen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patient representation during the evaluation of medicines by key decision makers such as regulatory agencies, Health Technology Assessment bodies, and healthcare payers is increasingly considered to add value to the appraisals and empowers patients, which means that they gain a more powerful voice over decisions and actions affecting their own health. As I myself suffer from the ultra-rare condition erythropoietic protoporphyria (EPP), I have participated as a patient expert in several discussions on access to afamelanotide, which currently is the only treatment for EPP and was approved in the European Union (EU) in 2014. As a molecular biologist with a PhD in EPP research, I consider myself having the necessary requirements to meaningfully contribute to such assessments. In this article, I share my personal experiences with regard to the discussions on access in Germany and England at the respective national competent authorities, the Federal Joint Committee, and the National Institute for Health and Care Excellence, respectively. In addition, I discuss the insights of the International Porphyria Patient Network, a group of highly empowered EPP patients effectively supporting national patient communities in their efforts to enable access to the afamelanotide treatment in their countries.

Zitieren

APA

Barman-Aksözen, J. (2019). Patient empowerment and access to medicines: Insights from a scientist-patient suffering from erythropoietic protoporphyria. Medicine Access @ Point of Care. https://doi.org/10.1177/2399202619865167

Vancouver

Barman-Aksözen J. Patient empowerment and access to medicines: Insights from a scientist-patient suffering from erythropoietic protoporphyria. Medicine Access @ Point of Care. 2019. doi:10.1177/2399202619865167

BibTeX
@article{BarmanAkszen2019,
  author = {Barman-Aksözen, Jasmin},
  title = {Patient empowerment and access to medicines: Insights from a scientist-patient suffering from erythropoietic protoporphyria},
  journal = {Medicine Access @ Point of Care},
  year = {2019},
  doi = {10.1177/2399202619865167}
}
Kostenlos starten →